Contacto

Synthetic inhibitors of galectin-1 and -3 selectively modulate homotypic cell aggregation and tumor cell apoptosis

Synthetic inhibitors of galectin-1 and -3 selectively modulate homotypic cell aggregation and tumor cell apoptosis

Turning ‘sweet’ on immunity: galectin-glycan interactions in immune tolerance and inflammation

Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes

Galectin 3 induces a distinctive pattern of cytokine and chemokine production in rheumatoid synovial fibroblasts via selective signaling pathways

Tumour-experienced T cells promote NK cell activity through trogocytosis of NKG2D and NKp46 ligands

Conveying glycan information into T-cell homeostatic programs: a challenging role for galectin-1 in inflammatory and tumor microenvironments

Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10

Tolerance and autoimmunity. Novel therapeutic approaches

Dissecting the signal transduction pathways triggered by galectin-glycan interactions in physiological and pathological settings

Nuclear factor (NF)-kappaB-dependent thyroid hormone receptor beta1 expression controls dendritic cell function via Akt signaling